Eden Research (EDEN) AI Stock Analysis

• Market Cap: £17.48M
• Dividend Yield: N/A
• Average Volume (3M): 564.08K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.05
• Revenue Growth: -8.14%
• EPS Growth: -51.72%
• Country: UK
• Employees: 23
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): >-0.01
• Shares Outstanding: 613,363,000
• 10 Day Avg. Volume: 506,108
• 30 Day Avg. Volume: 564,076
• PEG Ratio: 0.14
• Price to Book (P/B): 1.78
• Price to Sales (P/S): 4.90
• P/FCF Ratio: -5.86
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): >-0.01
• Revenue Forecast (FY): £6.13M

• Rating: 53 Neutral
• Price Target: 4.00 p ▲(53.85% Upside)
• Action: Reiterated Date: 01/21/26
• Date: Action: Reiterated 01/21/26

The score is held back primarily by weak financial performance—ongoing losses and persistently negative operating/free cash flow—despite revenue growth and a relatively stable balance sheet. Technicals are supportive due to strong price momentum above key moving averages, but extremely overbought readings raise pullback risk. Valuation is neutral-to-cautious because the negative P/E reflects lack of profitability and there is no dividend yield data.

Positive Factors

Sustainable product focus

Eden's core focus on plant‑based biopesticides positions it in a structurally growing sustainable agriculture market. Durable regulatory and farmer shifts away from synthetic inputs increase long‑term addressable market and support recurring demand for eco‑friendly formulations and licensing.

Negative Factors

Consistent negative cash flow

Persistent negative operating and free cash flow indicate ongoing cash burn from operations. Over months this constrains ability to self‑fund growth or commercialization, increases dependency on external financing, and can force dilutive capital raises or restrict investment in scale.

Eden Research Business Overview & Revenue Model

Company Description

Eden Research plc is a UK-based company that operates in the agricultural sector, specializing in the development and commercialization of sustainable biopesticides and natural products. The company primarily focuses on providing eco-friendly solu...

Read more

Eden Research plc is a UK-based company that operates in the agricultural sector, specializing in the development and commercialization of sustainable biopesticides and natural products. The company primarily focuses on providing eco-friendly solu...

How the Company Makes Money

Eden Research generates revenue primarily through the sale of its biopesticide products and licensing agreements for its patented technologies. The company earns income from direct sales to agricultural distributors and growers, as well as through...

Read more

Eden Research generates revenue primarily through the sale of its biopesticide products and licensing agreements for its patented technologies. The company earns income from direct sales to agricultural distributors and growers, as well as through...

Eden Research Financial Statement Overview

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Jun 2021
Income Statement
Total Revenue	3.62M	4.30M	3.19M	1.83M	1.23M	1.37M
Gross Profit	1.39M	1.87M	1.77M	207.14K	28.32K	9.63K
EBITDA	-1.93M	-1.59M	-6.24M	-1.83M	-2.72M	-1.87M
Net Income	-2.35M	-1.91M	-6.49M	-2.24M	-2.79M	-2.27M
Balance Sheet
Total Assets	13.46M	15.41M	16.59M	12.91M	15.03M	16.92M
Cash, Cash Equivalents and Short-Term Investments	1.85M	3.67M	7.41M	1.99M	3.83M	7.29M
Total Debt	571.86K	168.73K	229.77K	355.32K	398.35K	415.25K
Total Liabilities	2.85M	3.57M	3.05M	2.17M	2.20M	2.00M
Stockholders Equity	10.58M	11.82M	13.52M	10.72M	12.80M	14.91M
Cash Flow
Free Cash Flow	-710.00K	-3.60M	-1.80M	-1.74M	-3.34M	-2.92M
Operating Cash Flow	-209.90K	-1.01M	-1.70M	-683.10K	-1.62M	-1.02M
Investing Cash Flow	-2.72M	-2.48M	-1.72M	-1.05M	-1.73M	-1.90M
Financing Cash Flow	-150.87K	-155.53K	8.90M	-150.35K	-90.39K	9.71M

Eden Research Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.60
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:EDEN, the sentiment is Negative. The current price of 2.6 is below the 20-day moving average (MA) of 3.03, below the 50-day MA of 3.51, and below the 200-day MA of 3.09, indicating a bearish trend. The MACD of -0.19 indicates Negative momentum. The RSI at 30.07 is Neutral, neither overbought nor oversold. The STOCH value of 38.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:EDEN.

Eden Research Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CRDA	66 Neutral	£4.03B	60.70	6.17%	3.45%	2.36%	-13.99%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
TET	60 Neutral	£121.02M	32.05	3.64%	4.08%	1.12%	-0.70%
ELM	58 Neutral	£849.14M	-28.06	-6.85%	1.34%	-11.78%	-92.61%
EDEN	53 Neutral	£17.48M	-3.68	-20.21%	―	-8.14%	-51.72%
SYNT	51 Neutral	£69.84M	-1.25	-8.05%	―	-4.41%	2.29%
ITX	49 Neutral	£13.69M	-3.72	-19.63%	―	25.56%	35.12%

Eden Research Corporate Events